MALLORY SULLIVAN: Open Payments
NPI 1639800634 · PANAMA CITY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,106 in 62 payments from 11 companies in 2025. Trend: 2023 $888 · 2024 $1,152 · 2025 $1,106
Food & beverage: $1,106
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $246 |
| AstraZeneca Pharmaceuticals LP | 11 | $236 |
| ABBVIE INC. | 15 | $205 |
| Lilly USA, LLC | 7 | $129 |
| PFIZER INC. | 5 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Amgen Inc. | 2 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: AIRSUPRA, VRAYLAR, MOUNJARO, CAPLYTA, ELIQUIS, Wegovy, FARXIGA, UBRELVY.
Industry payments across FL — which companies pay providers there.
